Journal
ADVANCED SYNTHESIS & CATALYSIS
Volume 352, Issue 18, Pages 3121-3125Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adsc.201000473
Keywords
asymmetric catalysis; cyclic imines; enantioselectivity; hydrogenation; iridium
Categories
Funding
- National Institutes of Health [GM58832]
- Merck Co., Inc.
Ask authors/readers for more resources
A catalytic complex made from [Ir (COD)Cl](2) [di-mu-chloro-bis(1,5-cyclooctadiene)diridium(I)] precursor and (S,S)-f-Binaphane ((R,R)-1,1'-bis{bis{(R)-4,5-dihydro-3H-dinaphtho [1,2-c:2',1'-e]-phosphepino}ferrocene) ligand effectively catalyzed the enantioseselective hydrogenation of cyclic imines with high reactivity and good enantioselectivity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
